StonvexLoading…
StonvexStonvexStonvexCore line items from ODYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $82.00K | $3.02M | $2.58M | $2.43M |
Operating Income | $-5.34M | $-18.14M | $-13.71M | $-9.00M |
Net Income | $-5.18M | $-17.04M | $-12.76M | $-8.34M |
EPS (Diluted) | $-0.32 | $-1.07 | $-0.81 | $-0.54 |
Total Assets | $24.64M | $28.98M | $32.91M | $36.56M |
Total Liabilities | $3.48M | $3.55M | $3.80M | $3.96M |
Cash & Equivalents | $21.76M | $25.68M | $29.48M | $32.91M |
Free Cash Flow OCF − CapEx | $-4.26M | $-13.76M | $-9.86M | $-6.43M |
Shares Outstanding | 16.77M | 16.36M | 16.33M | 16.33M |